Zdrowie i gospodarka · 01/11/2019

FDA Releases Draft Guidance on Generic Drug User Fee Amendments of 2017

The Food and Drug Administration (FDA) has published a draft guidance for industry outlining the implementation of the Generic Drug User Fee Amendments of 2017 (GDUFA II) and the associated policies and procedures.